US6561978B1
Expired / Lapsed
US
⏱️ 0.0 years remaining
Devices and methods for frequent measurement of an analyte present in a biological system
Assignee: Lifescan IP Holdings LLC
•
Filing: 2000-02-11
•
Granted: 2003-05-13
•
Expires: 2020-02-11
Abstract
Abstract Devices and methods are provided for frequently measuring the concentration of an analyte present in a biological system. A monitoring system having at least two components is employed in order to allow separation of data collection from data processing and display. Such separation allows greater flexibility and convenience for the user.
Inventors
- 👤 Thomas E. Conn
- 👤 Russell Ford
- 👤 Russell O. Potts
- 👤 Pravin L. Soni
- 👤 Janet A. Tamada
- 👤 Michael J. Tierney
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-09 18:09
CPC Classifications
A; A61; A61B; A61B5/00; A61B5/68; A61B5/6801; A61B5/6802; A61B5/681; A61B5/0002; A61B5/0031; A61B5/145; A61B5/14532; A61B5/14546; A61B5/48; A61B5/4836; A61B5/4839; A61B5/683; A61B5/6831
Claims Analysis
Total Claims: 17
Claim 1
Independent Claim
288 words
A monitoring system for frequently measuring glucose present in a subject and providing to said subject self-monitoring of said glucose, said monitoring system comprising, (A) a first component to be placed in contact with a skin or mucosal surface of said subject comprising (i) an iontophoretic sampling mechanism for extracting the glucose from the subject, wherein said sampling mechanism is adapted for extracting the glucose across the skin or mucosal surface of said-subject; (ii) a sensing mechanism in operative contact with the glucose extracted by the sampling mechanism, wherein said sensing mechanism obtains a signal from the extracted glucose by detecting electrochemical signals produced at a biosensor electrode surface and said signal is specifically related to the glucose amount or concentration; and (iii) a first mechanism for providing operative communication with a second component of the monitoring system, wherein said operative communication comprises wireless communication technology that employs electromagnetic waves; wherein said first and second components are separately housed; and (B) the second component, comprising (i) a user interface; (ii) a second mechanism for providing operative communication with the first component, wherein said operative communication comprises wireless communication technology that employs electromagnetic waves, the second component (a) receives the signal from the first component, and (b) is capable of communicating with a third component remote from the subject being monitored, and (iii) a computing mechanism that converts the signal from the extracted glucose to an output indicative of the amount or concentration of glucose extracted by the sampling mechanism, wherein the second component displays said output and provides an alarm to the subject when the amount or concentration of glucose is above or below threshold values; wherein said second component is adapted to be carried by the subject.
Claim 2
Dependent Claim
288 words
A monitoring system for frequently measuring glucose present in a subject and providing to said subject self-monitoring of said glucose, said monitoring system comprising, (A) a first component to be placed in contact with a skin or mucosal surface of said subject comprising (i) an iontophoretic sampling mechanism for extracting the glucose from the subject, wherein said sampling mechanism is adapted for extracting the glucose across the skin or mucosal surface of said-subject; (ii) a sensing mechanism in operative contact with the glucose extracted by the sampling mechanism, wherein said sensing mechanism obtains a signal from the extracted glucose by detecting electrochemical signals produced at a biosensor electrode surface and said signal is specifically related to the glucose amount or concentration; and (iii) a first mechanism for providing operative communication with a second component of the monitoring system, wherein said operative communication comprises wireless communication technology that employs electromagnetic waves; wherein said first and second components are separately housed; and (B) the second component, comprising (i) a user interface; (ii) a second mechanism for providing operative communication with the first component, wherein said operative communication comprises wireless communication technology that employs electromagnetic waves, the second component (a) receives the signal from the first component, and (b) is capable of communicating with a third component remote from the subject being monitored, and (iii) a computing mechanism that converts the signal from the extracted glucose to an output indicative of the amount or concentration of glucose extracted by the sampling mechanism, wherein the second component displays said output and provides an alarm to the subject when the amount or concentration of glucose is above or below threshold values; wherein said second component is adapted to be carried by the subject.
Claim 3
Dependent Claim
30 words
The monitoring system of claim 1 , wherein the wireless communication technology employs low frequency electromagnetic waves in a frequency range of about 1 Hz. to about 1 Mega Hz.
Claim 4
Dependent Claim
31 words
The monitoring system of claim 1 , wherein the wireless communication technology employs medium frequency electromagnetic waves in a frequency range of about 1 Mega Hz. to about 500 Mega Hz.
Claim 5
Dependent Claim
31 words
The monitoring system of claim 1 , wherein the wireless communication technology employs high frequency electromagnetic waves in a frequency range of about 500 Mega Hz. to about 5 Giga Hz.
Claim 6
Dependent Claim
18 words
The monitoring system of claim 1 , wherein the second component relays command signals to the first component.
Claim 7
Dependent Claim
20 words
The monitoring system of claim 5 , wherein the command signals include signals to control operation of the sensing mechanism.
Claim 8
Dependent Claim
20 words
The monitoring system of claim 5 , wherein the command signals include signals to control operation of the sampling mechanism.
Claim 9
Dependent Claim
15 words
The monitoring system of claim 1 , wherein the second component can store glucose-related data.
Claim 10
Dependent Claim
12 words
The monitoring system claim 1 , wherein said subject is a mammal.
Claim 11
Dependent Claim
13 words
The monitoring system of claim 9 , wherein said mammal is a human.
Claim 12
Dependent Claim
48 words
The monitoring system of claim 1 , further comprising (C) a delivery device component comprising (i) a delivery device; and (ii) a third mechanism for providing operative communication with the first and second components, wherein the communication between first and second components and the third component is wireless.
Claim 13
Dependent Claim
16 words
The monitoring system of claim 11 , wherein the delivery device is implanted in the subject.
Claim 14
Dependent Claim
16 words
The monitoring system of claim 11 , wherein the delivery device is external to the subject.
Claim 15
Dependent Claim
15 words
The monitoring system of claim 11 , wherein the delivery device comprises an insulin pump.
Claim 16
Dependent Claim
47 words
The monitoring system of claim 1 , further comprising (C) the third component comprising (i) a modem or personal computer; and (ii) a third mechanism for providing operative communication with the first and second components, wherein said operative communication comprises wireless communication technology that employs electromagnetic waves.
Claim 17
Dependent Claim
22 words
The monitoring system of claim 15 , wherein the modem or personal computer is operably linked to a wide area network (WAN).
References Cited (Backward Citations)
US4178916A
Cited
US4509531A
Cited
US4703756A
Cited
US5279543A
Cited
US5730714A
Cited
US5062841A
Cited
US5063081A
Cited
US5362307A
Cited
US5112614A
Cited
US5140985A
Cited
US5636632A
Cited
WO1991012772A1
Cited
US5077753A
Cited
US5113869A
Cited
US5875186A
Cited
WO1995002357A1
Cited
US5830132A
Cited
US5458140A
Cited
US5569186A
Cited
US5507288A
Cited
US5507288B1
Cited
US5771890A
Cited
WO1996000109A1
Cited
US6023629A
Cited
WO1996000110A1
Cited
US5462051A
Cited
US5807375A
Cited
US5914701A
Cited
WO1996036134A1
Cited
US5721783A
Cited
US5995860A
Cited
WO1997002811A1
Cited
US5989409A
Cited
WO1997010499A1
Cited
US5827183A
Cited
US5735273A
Cited
WO1997010356A1
Cited
WO1997024059A1
Cited
US5954685A
Cited
US6049727A
Cited
US5882300A
Cited
US6159147A
Cited
WO1998042252A1
Cited
US6277067B1
Cited
US5897033A
Cited
US5982297A
Cited
WO1999040848A1
Cited
US6059736A
Cited
US6134461A
Cited
EP0942278A2
Cited
US6024699A
Cited
US6175752B1
Cited
WO1999058190A1
Cited
WO1999058973A1
Cited
WO1999058050A1
Cited
WO1999058051A1
Cited
US6248067B1
Cited
WO2000047109A1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2006-05-12 | 2006-11-11 | 2007-05-13 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2010-05-12 | 2010-11-11 | 2011-05-13 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2014-05-12 | 2014-11-11 | 2015-05-13 | $7700.00 | Window Closed / Lapsed |